drugset / Trial / NCT00202540

Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment Patients

NCT00202540 ↗

Phase 2 Terminated 38 enrolled Servier
RandomizedParallel-groupDouble-blind

Summary

The purpose of this study is to demonstrate a long term efficacy of S18986 versus placebo on episodic memory performance in patients with MCI

Timeline

Start
2005-06
Primary completion
2006-03-29
Completion
2006-03-29

Drugs

EvaluationDrugModalityDoseRoute
Subject S18986 Unknown 15 mg Oral
Subject S18986 Unknown 50 mg Oral